EMGALITY
Active substance: galcanezumab
INJECTION, SOLUTION · GALCANEZUMAB 120 mg/mL
United StatesActive
Marketing holder: Eli Lilly and Company
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- GALCANEZUMAB · 120 mg/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12091-69e3-7bc3-9d96-f06864ced9b6,01a12098-498f-725b-9f33-2b839b0778e8,01a1209b-0395-73c0-9e67-ac8c22199fbf;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0002-2377
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 0002-2377 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0002-2377 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0002-2377 · Verified 2026-10-09 · open in source